We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TFM
776
DELISTED
THE FRESH MARKET, INC COM STK
TFM
| $734K | ﹤0.01% |
+18,054
| New | +$704K |
|
777
SPX Corp
SPXC
$10.7B
| $733K | ﹤0.01% |
34,270
-206,774
| -86% | -$4.44M |
|
778
Cenovus Energy
CVE
$54.3B
| $725K | ﹤0.01% |
+43,000
| New | +$793K |
|
779
United Rentals
URI
$71.3B
| $723K | ﹤0.01% |
7,929
+5,338
| +206% | +$480K |
|
|
SUP
780
DELISTED
Superior Industries International
SUP
| $722K | ﹤0.01% |
38,125
-18,183
| -32% | -$346K |
|
781
Alaska Air
ALK
$5.36B
| $717K | ﹤0.01% |
10,830
-432,429
| -98% | -$28.1M |
|
|
KEG
782
DELISTED
KEY ENERGY SERVICES INC
KEG
| $696K | ﹤0.01% |
382,498
-212,084
| -36% | -$386K |
|
|
YELL
783
DELISTED
Yellow Corporation Common Stock
YELL
| $695K | ﹤0.01% |
38,676
+27,900
| +259% | +$517K |
|
784
CEVA Inc
CEVA
$909M
| $693K | ﹤0.01% |
32,528
-6,363
| -16% | -$125K |
|
785
Avery Dennison
AVY
$13.5B
| $684K | ﹤0.01% |
12,937
-55,815
| -81% | -$2.95M |
|
786
Children's Place
PLCE
$58M
| $680K | ﹤0.01% |
+10,600
| New | +$638K |
|
787
Euronet Worldwide
EEFT
$2.65B
| $677K | ﹤0.01% |
+11,529
| New | +$611K |
|
|
VIAB
788
DELISTED
Viacom Inc. Class B
VIAB
| $662K | ﹤0.01% |
+9,690
| New | +$669K |
|
789
DHI Group
DHX
$164M
| $657K | ﹤0.01% |
73,608
+45,298
| +160% | +$411K |
|
790
Murphy Oil
MUR
$5.07B
| $657K | ﹤0.01% |
+14,100
| New | +$681K |
|
791
iShares MSCI India ETF
INDA
$6.61B
| $651K | ﹤0.01% |
+20,300
| New | +$654K |
|
792
Ezcorp Inc
EZPW
$1.68B
| $647K | ﹤0.01% |
70,916
+38,773
| +121% | +$413K |
|
|
SPR
793
DELISTED
Spirit AeroSystems
SPR
| $642K | ﹤0.01% |
12,297
-45,428
| -79% | -$2.17M |
|
|
EFOR
794
Everforth Inc
EFOR
$1.34B
| $635K | ﹤0.01% |
16,558
+1,230
| +8% | +$44.8K |
|
|
CCMP
795
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $632K | ﹤0.01% |
12,656
-13,739
| -52% | -$675K |
|
796
First Community Bankshares
FCBC
$896M
| $630K | ﹤0.01% |
35,940
+8,479
| +31% | +$139K |
|
|
ARI
797
Apollo Commercial Real Estate
ARI
$877M
| $624K | ﹤0.01% |
+36,300
| New | +$611K |
|
798
Univest Financial
UVSP
$1.17B
| $621K | ﹤0.01% |
31,397
-7,886
| -20% | -$152K |
|
799
Pentair
PNR
$10.8B
| $616K | ﹤0.01% |
+14,592
| New | +$635K |
|
800
Flotek Industries
FTK
$1.35B
| $613K | ﹤0.01% |
6,936
-44,887
| -87% | -$4.39M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.